Nordihydroguaiaretic acid (NDGA)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nordihydroguaiaretic acid (NDGA), covering 2014-04-09 to 2014-04-09. Get the full timeline:
Most recent: Clinical Trial Update: Pharmacokinetic and Efficacy Study of Nordihydroguaiaretic Acid (NDGA) in Non Metastatic Recurrent Prostate Cancer [Phase 2]